
Rhizome AI YC-Bewerbung
Rhizome AI durchlief Y Combinator im Winter 2026-Batch als ein B2B-Unternehmen. Unten: Was das Unternehmen tut, wer es gegründet hat und seine Bewerbung bei YC, Frage für Frage im echten YC-Formular rekonstruiert.
- YC-Batch
- Winter 2026
- Branche
- B2B
- Teamgröße
- 1
- Status
- Active
- Gestartet
- 2026
Gründer
Chetan MishraFounder
Was Rhizome AI tut
It takes 500,000 days of office work to bring a drug to market. We want to make it 5. To get there, we need agents doing most of the work. Today, our research agent is the best way to know what the FDA thinks. Users ask a question and get an answer backed by up to 1,000 documents, where each statement has a citation. It’s the best because we have the best retrieval engine. We’ve tuned it on our life science-specific dataset, and we find what others miss. As more teams use Rhizome, we gain more data on what regulatory professionals actually need, which makes retrieval even better. This flywheel is how we become the retrieval engine that powers all human and agent work in life sciences. Chetan started his career as a research engineer, but quickly realized he enjoyed building more than research. He joined EvolutionaryScale as their sole founding product engineer, launching their developer-scientist platform and scaling to tens of thousands of users and billions of API calls. He was also #16 at Instabase helping banks with document processing, closing $7m as the technical closer. Agents can do magical things today, but most in life sciences only use them to edit emails. Agents are missing the context they need to 100x the number of drugs we can bring to market. Rhizome AI is focused on that critical problem.
Rhizome AIs YC-Bewerbung, rekonstruiert
Y Combinator Bewerbung
Rhizome AI, Winter 2026 Batch. Die echten Fragen des Antrags, beantwortet aus öffentlichen Daten.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Rhizome AI
Agent Platform for Life Sciences
We built a research agent that helps regulatory professionals understand FDA guidance by answering their questions with citations from up to 1,000 relevant documents. It's powered by a retrieval engine tuned specifically on life science datasets that finds regulatory information others miss. Our product aims to automate much of the work involved in navigating drug approval processes.
I live in New York City and the company is based there and remotely distributed.
New York is a major life sciences hub, and remote lets us access talent and customers globally. This fits our need to stay close to regulatory experts and life sciences teams while keeping flexibility.
21 weitere Antworten in der vollständigen Bewerbung
Founders, Progress, Idea, Equity, Curious, Batch Preference sind in der Vollversion. Erstelle ein kostenloses Konto, um es in YC Insights neben jedem anderen YC-Batch zu öffnen.
Häufig gestellte Fragen
Ist das die echte YC-Bewerbung von Rhizome AI?
Nein. Y Combinator hält eingereichte Bewerbungen privat. Dies ist eine Rekonstruktion: die echten Fragen des YC-Formulars, beantwortet aus den öffentlichen Daten von Rhizome AI (Veröffentlichungsnotizen, Gründerhintergründe, Produktbeschreibung). Sie zeigt, wie sich ein Unternehmen wie Rhizome AI bei YC präsentieren würde, nicht den Text, den sie eingereicht haben.
In welchem YC-Batch war Rhizome AI?
Rhizome AI war Teil des Y Combinator Winter 2026-Batches.
Wer hat Rhizome AI gegründet?
Rhizome AI wurde von Chetan Mishra gegründet.
Was macht Rhizome AI?
Agent Platform for Life Sciences
Wie lese ich die vollständige, rekonstruierte Bewerbung?
Erstelle ein kostenloses Round Funded Konto. Die vollständige 26-Antwort-Version der Bewerbung von Rhizome AI, und jede andere YC-Kohorte, findest du in YC Insights.